C-Mer Eye Care Holdings Ltd
HKEX:3309

Watchlist Manager
C-Mer Eye Care Holdings Ltd Logo
C-Mer Eye Care Holdings Ltd
HKEX:3309
Watchlist
Price: 1.23 HKD Market Closed
Market Cap: HK$1.5B

P/E

14.9
Current
197%
Cheaper
vs 3-y average of -15.4

Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.

P/E
14.9
=
Market Cap
HK$1.5B
/
Net Income
HK$100.4m

Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.

P/E
14.9
=
Market Cap
HK$1.5B
/
Net Income
HK$100.4m

Valuation Scenarios

C-Mer Eye Care Holdings Ltd is trading below its 5-year average

If P/E returns to its 5-Year Average (18.5), the stock would be worth HK$1.53 (24% upside from current price).

Statistics
Positive Scenarios
1/3
Maximum Downside
-32%
Maximum Upside
+24%
Average Downside
7%
Scenario P/E Value Implied Price Upside/Downside
Current Multiple 14.9 HK$1.23
0%
5-Year Average 18.5 HK$1.53
+24%
Industry Average 10.2 HK$0.84
-32%
Country Average 12.7 HK$1.05
-15%

Forward P/E
Today’s price vs future net income

Not enough data available to calculate forward P/E

Market Distribution

In line with most companies in Hong Kong
Percentile
57th
Based on 1 249 companies
57th percentile
14.9
Low
0 — 8.8
Typical Range
8.8 — 19.3
High
19.3 —
Distribution Statistics
Hong Kong
Min 0
30th Percentile 8.8
Median 12.7
70th Percentile 19.3
Max 6 260.9

C-Mer Eye Care Holdings Ltd
Glance View

Market Cap
1.5B HKD
Industry
Health Care

C-MER Eye Care Holdings Ltd. engages in the provision of treatments and therapy services for ophthalmic diseases. The company employs 1,461 full-time employees The company went IPO on 2018-01-15. The ophthalmic services are surgeries for the treatment of cataract, glaucoma and strabismus, as well as eye diseases, including corneal and vitreoretinal diseases. The firm also sells vision aid products including glasses and lens, as well as pharmaceutical products. The firm's main subsidiaries are C-MER Eye Care Medical Group Limited and C-MER Eye Care Group Limited, among others.

Intrinsic Value
1.68 HKD
Undervaluation 27%
Intrinsic Value
Price HK$1.23
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett